Effects of Lipoxin A4 on antimicrobial actions of neutrophils in sepsis

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 94, Issue , 2015, Pages 55-64

  Wu, B ^a   Walker, J ^a   Spur, B ^a   Rodriguez, A ^a   Yin, K ^a  

^a ROWAN UNIVERSITY   (United States)

Author keywords

Bacteria; Flow cytometry; Lipoxin A4; Neutrophils; Phagocytosis; Sepsis

Indexed keywords

LIPOXIN A; LIPOXIN; NONSTEROID ANTIINFLAMMATORY AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BACTERIAL CLEARANCE; BACTERIAL LOAD; CELL PHAGOCYTOSIS; CONTROLLED STUDY; EX VIVO STUDY; FATTY ACID ANALYSIS; IN VIVO STUDY; LEUKOCYTE FUNCTION; LEUKOCYTE MIGRATION; MALE; NEUTROPHIL; NONHUMAN; PERITONEUM; PHENOTYPE; PRIORITY JOURNAL; RAT; SEPSIS; ANIMAL; BACTEREMIA; DISEASE MODEL; DRUG EFFECTS; IMMUNOLOGY; LEUKOCYTE; LEUKOCYTE ACTIVATION; MICROBIOLOGY; PHAGOCYTOSIS; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

BACTERIA (MICROORGANISMS); RATTUS;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BACTEREMIA; BACTERIAL LOAD; DISEASE MODELS, ANIMAL; LEUKOCYTES; LIPOXINS; MALE; NEUTROPHIL ACTIVATION; NEUTROPHILS; PERITONEUM; PHAGOCYTOSIS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84923915316     PISSN: 09523278     EISSN: 15322823     Source Type: Journal    
DOI: 10.1016/j.plefa.2014.11.005     Document Type: Article

References (54)

1. Delano M.J., Thayer T., Gabrilovich S., et al. Sepsis induces early alterations in innate immunity that impact mortality to secondary infection. J. Immunol. 2011, 186:195-202.
2. Ellaban E., Bolgos G., Remick D. Selective macrophage suppression during sepsis. Cell Immunol. 2004, 231:103-111.
3. Mannick J.A. Trauma, sepsis and immune defects p15-21. Host Defense Dysfunction in Trauma, Shock and Sepsis 1993, Springer-Verlag, Berlin. E. Faist, J.L. Meakins, F.W. Schildberg (Eds.).
4. Liaw W.J., Chen T.H., Lai Z.Z., et al. Effects of a membrane permeable radical scavenger, tempol, on intraperitoneal sepsis-induced organ injury in rats. Shock 2005, 23:88-96.
5. Ritter C., Andrades M.E., Reinke A., Menna-Barreto S., Moreira J.C., Dal-Pizzol F. Treatment with N-acteylcysteine plus deferoxamine protects rats against oxidative stress and improves survival in sepsis. Crit. Care Med. 2004, 32:342-349.
6. Alves-Filho J.C., Freitas A., Spiller F., Souto F.O., Cunha.F.Q. The role of neutrophils in severe sepsis. Shock 2008, 30:3-9.
7. Craciun F.L., Schuller E.R., Remick D.G. Early enhanced local neutrophil recruitment in peritonitis-induced sepsis improves bacterial clearance and survival. J. Immunol. 2010, 185:6930-6938.
8. Kasten K.R., Prakash P.S., Unsinger J., et al. Interleukin-7 (IL-7) treatment accelerates neutrophil recruitment through gamma delta T-cell IL-17 production in a murine model of sepsis. Infect. Immun. 2010, 78:4714-4722.
9. Robertson C.M., Perrone E.E., McConnell K.W., et al. Neutrophil depletion causes a fatal defect in murine pulmonary Staphylococcus aureus clearance. J. Surg. Res. 2008, 150:278-285.
10. Danikas D.D., Karakantza M., Theodorou G.L., Sakellaropoulos G.C., Gogos C.A. Prognostic value of phagocytic activity of neutrophils and monocytes in sepsis. Correlation to CD54 and CG14 antigen expression. Clin. Exp. Immunol. 2008, 154:87-97.
11. Riedemann N.C., Guo R.F., Bernacki K.D., et al. Regulation by C5a of neutrophil activation during sepsis. Immunity 2003, 19:193-202.
12. El Kebir D., Jozsef L., Pan W., Filep J.G. Myeloperoxidase delays neutrophil apoptosis through CD 11b/CD 18 integrins and prolongs inflammation. Circ. Res. 2008, 103:352-359.
13. Fialkow L., Fochesatto Filho L., Bozzetti M.C., et al. Neutrophil apoptosis: a marker of disease severity in sepsis and sepsis-induced acute respiratory distress syndrome. Crit. Care. 2006, 10:R155-R168.
14. Fox S., Leitch A., Duffin R., Haslett C., Rossi A.G. Neutrophil apoptosis: relevance to innate immune response and inflammatory disease. J. Innate Immun. 2010, 2:216-227.
15. Kennedy A.D., DeLeo F.R. Neutrophil apoptosis and the resolution of infection. Immunol. Res. 2009, 43:25-61.
16. Paunel-Gorgulu A., Kirichevska T., Logters T., Windolf J., Flohe S. Molecular mechanisms underlying delayed apoptosis in neutrophils from multiple trauma patients with and without sepsis. Mol. Med. 2012, 18:325-335.
17. Fexby S., Bjarnsholt T., Jensen P.Ø., et al. Biological Trojan horse: antigen 43 provides specific bacterial uptake and survival in human neutrophils. Infect. Immun. 2007, 75:30-34.
18. Yang Q., Ghose P., Ismail N. Neutrophils mediate immunopathology and negatively regulate protective immune responses during fatal bacterial infection-induced toxic shock. Infect. Immun. 2013, 8195:1751-1763.
19. Chiang N., Gronert K., Clish C.B., O'Brien J.A., Freeman M.W., Serhan C.N. Leukotriene B4 receptor transgenic mice reveal novel protective roles for lipoxins and aspirin-triggered lipoxins in reperfusion. J. Clin Invest. 1999, 104:309-316.
20. Kantarci A., Van Dyke T.E. Lipoxin signaling in neutrophils and their role in periodontal disease. Prostag. Leukotr. Ess. Fatty Acids 2005, 75:289-299.
21. Levy B., Clish C.B., Schmidt B., Gronert K., Serhan C.N. Lipid mediator class switching during acute inflammation signals in resolution. Nat. Immunol. 2001, 2:612-619.
22. Mitchell S., Thomas G., Harvey K., et al. Lipoxins, aspirin-triggered epi-lipoxins, lipoxin stable analogues, and the resolution of inflammation: stimulation of macrophage phagocytosis of apoptotic neutrophils in vivo. J. Am. Soc. Nephrol. 2002, 13:2497-2507.
23. 4 analogues inhibit leukocyte recruitment to Porphyromonas gingivalis: a role for cytclooxygenase-2 and lipoxins in periodontal disease. Biochemistry 2000, 39:4761-4768.
24. Serhan C.N., Chiang N., Van Dyke T.E. Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat. Rev. Immunol. 2008, 8:349-361.
25. 4, is protective in experimental ischemic acute renal failure. J. Am. Soc. Nephrol. 2002, 13:1657-1662.
26. Bannenberg G., Moussignac R.L., Gronert K., et al. Lipoxins and novel 15-epi-lipoxin analogs display potent anti-inflammatory actions after oral administration. Br. J. Pharmacol. 2004, 143:43-52.
27. 4 analogs attenuate induction of intestinal epithelial proinflammatory gene expression and reduce the severity of dextran sodium sulfate-induced colitis. J. Immunol. 2002, 168:5260-5267.
28. 4 analog attenuates lipopolysaccharide-induced acute lung injury in mice: the role of heme oxygenase-1. Crit. Care Trauma 2007, 104:369-377.
29. Bafica A., Scanga C.A., Serhan C.N., et al. Host control of Mycobacterium tuberculosis is regulated by 5-lipoxygenase-dependent lipoxin production. J. Clin. Invest. 2005, 115:1601-1606.
30. 4 in the induction of macrophage death. J. Exp. Med. 2008, 205:2791-2801.
31. 4 increases survival by decreasing systemic inflammation and bacterial load in sepsis. Shock 2011, 36:410-417.
32. 4 analog. Prostag. Leukot. Essent. Fatty Acids 2013, 89:47-53.
33. 4 and lipoxin B4 from butadiene. Tetrahedron Lett. 2000, 41:823-826.
34. 4 with antibiotics protects mice from Escherichia coli - induced sepsis. Crit. Care Med. 2014, 42:e288-e295.
35. 4. Pediatr. Res. 2008, 64:393-398.
36. 2 is a potent regulator of leukocytes and controls microbial sepsis. Nature 2009, 461:1287-1291.
37. Rittirsch D., Huber-Lang M.S., Flierl M.A., Ward P.A. Immunodesign of experimental sepsis by cecal ligation and puncture. Nat. Protoc. 2009, 4:31-36.
38. Ozment T.R., Ha T., Breuel K.F., et al. Scavenger receptor class a plays a central role in mediating mortality and the development of the pro-inflammatory phenotype in polymicrobial sepsis. PLoS Pathog. 2012, 8:e1002967. 10.1371/journal.ppat.1002967.
39. Barbuddhe S.B., Malik S.V., Gupta L.K. Effect of in vitro monocyte activation by Listeria monocytogenes antigens on phagocytosis and production of reactive oxygen and nitrogen radicals in bovines. Vet. Immunol. Immunopathol. 1998, 64:149-159.
40. Chiang N., Fredman G., Backhed F., et al. Infection regulates pro-resolving mediators that lower antibiotic requirements. Nature 2012, 482:524-528.
41. Prince L.R., Bianchi S.M., Vaughan K.M., et al. Subversion of a lysosomal pathway regulating neutrophil apoptosis by a major bacterial toxin, pyocyanin. J. Immunol. 2008, 180:3502-3511.
42. Mishra M., Byrd M.S., Sergeant S., et al. Pseudomonas aeruginosa Psi polysaccharide reduces neutrophil phagocytosis and the oxidative response by limiting complement-mediated opsonization. Cell Microbiol. 2012, 14:95-106.
43. Ren Y., Xie Y., Jiang G., et al. Apoptotic cells protect mice against lipopolysaccharide-induced shock. J. Immunol. 2008, 180:4978-4985.
44. El Kebir D., Jozsef L., Pan W., Petasis N.A., Serhan C.N., Filep J.G. Aspirin-triggered lipoxins override the apoptosis-delaying action of serum amyloid A in human neutrophils: a novel mechanism for resolution of inflammation. J. Immunol. 2007, 179:616-622.
45. 4 receptor: implications for resolution of inflammation. J. Leukoc. Biol. 2008, 84:600-606.
46. Afford S.C., Pongracz J., Stockley R.A., Crocker J., Burnett D. The induction by human interleukin-6 of apoptosis in the promonocytic cell line U937 and human neutrophils. J. Biol. Chem. 1992, 267:21612-21616.
47. Tang B.M., McLean A.S., Dawes I.W., Huang S.J., Lin R.C. The use of gene-expression profiling to identify candidate genes in human sepsis. Am. J. Respir. Crit Care Med. 2007, 176:676-684.
48. 4 inhibits Porphyrmonas gingivalis-induced aggregation and reactive oxygen species production by modulating neutrophil-platelet interaction and CD11b expression. Infect. Immun. 2011, 79:1489-1497.
49. 4 inhibits human neutrophil superoxide anion generation by regulating polyisoprenyl diphosphate phosphatase 1. FASEB J. 2013, 27:2733-2741.
50. Lennartz M.R. Phospholipases and phagocytosis: the role of phospholipid-derived second messengers in phagocytosis. Int. J. Biochem. Cell Biol. 1999, 31:415-430.
51. Zou L., Feng Y., Zhang M., Li Y., Chao W. Nonhematopoietic toll-like receptor 2 contributes to neutrophil and cardiac function impairment during polymicrobial sepsis. Shock 2011, 36:370-380.
52. Schwab J.M., Chiang N., Arita M., Serhan C.N. Resolvin E1 and Protectin D1 activate inflammation-resolution programmes. Nature 2007, 447:869-874.
53. Lennartz M.R., Brown E.J. Arachidonic acid is essential for IgG Fc receptor-mediated phagocytosis by human monocytes. J. Immunol. 1991, 147:621-626.
54. 4 stimulate the release but not the oxygenation of arachidonic acid in human neutrophils: dissociation between lipid remodeling and adhesion. J. Cell Physiol. 1990, 143:512-523.